Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer
Mené sur des patients atteints d'un cancer et souffrant de troubles dépressifs, cet essai de phase II évalue l'efficacité d'une intervention combinant psychothérapie de groupe et administration de psilocybine pour diminuer les symptômes de dépression, d'anxiété, de démoralisation et soulager la douleur
Several recent studies have investigated psilocybin as a novel therapeutic compound for the treatment of existential distress in patients with cancer, demonstrating persistent, positive effects on mood. This editorial discusses two articles in the current issue of Cancer that report findings of a group-based psilocybin-assisted intervention for treatment of depression in patients diagnosed with cancer.
Cancer , éditorial, 2022